US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.605
  • +0.035+6.09%
Close Sep 9 16:00 ET
  • 0.580
  • -0.024-4.00%
Post 20:01 ET
24.26MMarket Cap-650P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.24
-0.18
+0.06
Beat Est.
-47.97%
-12.50%
+23.92%
Analyst Rating
Buy

Sep 6, 2024

Cognition Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Cognition Therapeutics Earnings Reports

  • Cognition Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:19 ET

  • Cognition Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 07:49 ET

  • Cognition Therapeutics | 10-K: FY2023 Annual Report

    Mar 26 16:21 ET

  • Cognition Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 6, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg